Cite Filings / CLRB / 0001213900-25-062102

Feed Companies Filings Check

Sign in

SCHEDULE 13G

Statement of Beneficial Ownership

Cellectar Biosciences, Inc. Filed 2025-07-08 Acc 0001213900-25-062102

Documents 1

SCHEDULE 13G Statement of Beneficial Ownership , xslSCHEDULE_13G_X01/primary_doc.xml

Around this filing

2025-08-08 SCHEDULE 13G Statement of Beneficial Ownership
2025-07-08 SCHEDULE 13G Statement of Beneficial Ownership
2025-07-03 4 Chief Executive Officer bought 10,000 shares at $4.99 ($49,900)
2025-07-03 4 Chief Operating Officer bought 10,000 shares at $4.99 ($49,900)
2025-07-03 4 Chief Financial Officer bought 5,000 shares at $4.99 ($24,950)
2025-07-02 424B4 Prospectus
2025-07-01 EFFECT Notice of Effectiveness

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13G_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…